Fibroblast growth factor 23, endothelium biomarkers and acute kidney injury in critically-ill patients.
Fernanda Macedo de Oliveira NevesCamila Barbosa AraújoDaniele Ferreira de FreitasBianca Fernandes Távora ArrudaLeonardo José Monteiro de Macêdo FilhoVivian Brito SallesGdayllon Cavalcante MenesesAlice Maria Costa MartinsAlexandre Braga LibórioPublished in: Journal of translational medicine (2019)
The association between FGF23 and AKI are mediated by endothelium-related biomarkers, mainly VCAM-1, AGPT2 and syndecan-1. Moreover, the statistical models show that syndecan-1, a biomarker of endothelial glycocalyx dysfunction, seems to be the initial mediator between FGF23 and severe AKI.